ESR1 and prostate cancer: Taxane-induced microtubule dependent androgen receptor signaling dysfunction (extensively studied in the field of prostate cancer) and the potential cross-reactivity of estrogen receptor ligands inhibiting taxane-tubulin binding provides the most robust evidence for developing a hypothesis for male-specific toxicity and female-specific protection after paclitaxel exposure.